BioReference Laboratories | GenomeWeb

BioReference Laboratories

Going forward, Natera said it will market its Panorama NIPT assay and carrier screening test Horizon directly to physicians.

Around 16,000 4Kscore prostate cancer tests were performed in Q3, which is a 365 percent increase over Q3 2015.

Experts said that the EMR is a crucial channel for aggregating clinical insights from multiple sources, but plenty of work is needed to achieve broader adoption.

The company, which is part of Opko Health's BioReference Laboratories, recently hired a new managing director, who plans to expand the firm's market and testing portfolio.

The two entities also plan to work together using the data generated from the tests to do added research.

The performance of WES for genetically heterogeneous disorders improves significantly when testing is performed on the proband and two or more family members.

The partners will develop an NGS panel for solid and liquid tumors for use in personalized oncology.

The company joins the Pistoia Alliance as a participating member and the Global Alliance for Genomics and Health as an organizational member. 

In a statement to GenomeWeb, Myriad noted that all seven of its cases are now settled, "which ends the BRCA litigation."

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.